Pfizer’s Covid-19 Vaccine is 95% Effective and Has No Serious Side Effects, Based on Trial Results

Pfizer’s CORONAVIRUS VACCINE is 95% effective and has passed its security controls, according to other data from the firm.

The pharmaceutical giant and its partner BioNTech released interim results last week showing that the jab could prevent more than 90% of people from developing Covid-19.

That data was based on the first 94 volunteers to develop Covid-19, but additional figures released today are based on the first 170 cases of the virus in the clinical trial.

The vaccine has been tested in 43,500 people in six countries and no safety concerns have been raised.

Another blow, from the American firm Moderna, showed this week in the first data that it has an effectiveness of almost 95%.

The Pfizer vaccine has been shown to produce an antibody and T-cell response in the body to fight the coronavirus.

Pfizer and BioNTech expect to be able to produce up to 50 million doses of vaccines globally in 2020 and up to 1.3 billion in 2021.

Yesterday, Pfizer CEO Albert Bourla said the company is preparing to apply for an emergency use authorization from the US Food and Drug Administration.